PARITHERA
Precision oncology includes new ways of treating cancer such as targeted therapies and immunotherapies. These approaches are more specific and effective than current treatments. In the near future, they will considerably reduce worldwide cancer burden. As of today, only a fraction of the 18 million yearly diagnosed patients benefit from precision oncology. To increase the number of beneficiaries, new diagnostic tools are needed to match the specific needs of precision oncology to define patients' eligibility and monitor treatment response.
PARITHERA
Social Links:
Industry:
Therapeutics
Founded:
2021-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.parithera.com
Total Employee:
1+
Status:
Active
Total Funding:
100 K CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Amazon Google Apps For Business Microsoft Azure DNS Google
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
VetSource
VetSource is a pharmaceuticals company providing pet care medication and vaccination services.
Current Employees Featured
Founder
Investors List
École Polytechnique Fédérale de Lausanne
École Polytechnique Fédérale de Lausanne investment in Grant - Parithera
Official Site Inspections
http://www.parithera.com
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
